In millions, except per share items | Jan-31-23 | Oct-31-22 | Apr-30-22 | Jan-31-22 | Oct-31-21 | Jul-31-21 | Apr-30-21 | Jan-31-21 |
| 10-Q | 10-Q | 10-Q | 10-Q | 10-Q | 10-K | 10-Q | 10-Q |
Total revenues | | | 2.1 | 2.2 | 3.1 | 4.0 | 4.2 | 4.5 |
Revenue growth | | | -50.3% | -50.3% | -34.6% | -19.1% | -16.4% | -14.3% |
Cost of goods sold | | | 25.0 | 25.0 | 25.0 | 0.0 | 0.0 | 0.0 |
Gross profit | | | -22.9 | -22.8 | -21.9 | 4.0 | 4.2 | 4.5 |
Gross margin | | | -1085.4% | -1024.1% | -704.1% | 100.0% | 100.0% | 100.0% |
Selling, general and administrative [+] | | | 29.9 | 29.0 | 30.1 | 20.4 | 11.1 | 10.2 |
Sales and marketing | | | 16.2 | | 18.0 | | 8.4 | 7.4 |
General and administrative | | | | 13.7 | | 12.1 | | |
Research and development | | | 1.8 | 1.6 | 6.5 | 4.9 | 4.4 | 3.8 |
Equity in earnings | | | | | -0.3 | 0.4 | 0.4 | 0.4 |
Other operating expenses | | | | 3.3 | | | | |
EBITDA [+] | | | -58.4 | -57.1 | -58.8 | -21.0 | -10.9 | -9.1 |
EBITDA growth | | | 436.9% | 525.3% | 707.0% | 227.3% | 75.0% | 58.6% |
EBITDA margin | | | -2770.0% | -2568.5% | -1892.0% | -528.1% | -256.5% | -204.1% |
Depreciation and amortization | | | 0.8 | 0.6 | 1.0 | 1.5 | 1.5 | 1.8 |
EBIT [+] | | | -59.2 | -57.7 | -59.9 | -22.4 | -12.4 | -10.9 |
EBIT growth | | | 377.1% | 427.8% | 556.0% | 171.1% | 53.0% | 43.6% |
EBIT margin | | | -2807.8% | -2596.3% | -1925.5% | -564.8% | -292.6% | -244.4% |
Non-recurring items [+] | | | | | 17.3 | | | 7.0 |
Asset impairment | | | | | 17.3 | | | 7.0 |
Interest expense, net [+] | | | 0.2 | | -0.2 | 0.0 | 0.0 | |
Interest expense | | | 0.4 | 0.0 | 0.0 | 0.0 | 0.0 | |
Interest income | | | 0.2 | | 0.2 | | 0.0 | |
Other income (expense), net [+] | | | -78.8 | -77.8 | -74.9 | 4.3 | 5.2 | 4.1 |
Gain (loss) on foreign currency transactions | | | | | | | | 0.0 |
Pre-tax income | | | -148.4 | -145.6 | -151.9 | -25.1 | -14.3 | -13.8 |
Income taxes | | | 0.6 | 0.6 | 0.6 | 0.0 | 0.0 | 0.0 |
Tax rate | | | | -0.4% | | | 0.1% | 0.2% |
Minority interest | | | -17.5 | -17.6 | -17.4 | 0.0 | 0.1 | 0.1 |
Earnings from continuing ops | | | -131.4 | -128.4 | -134.8 | -24.8 | -17.9 | -17.5 |
Earnings from discontinued ops | | | | -1.1 | -0.5 | | | |
Net income | | | -132.5 | -129.5 | -135.3 | -24.8 | -17.9 | -17.5 |
Net margin | | | -6281.5% | -5822.8% | -4353.3% | -623.7% | -422.1% | -391.3% |
|
Basic EPS [+] | | | ($7.01) | ($7.15) | ($7.89) | ($1.52) | ($1.11) | ($1.10) |
Growth | | | 531.0% | 548.9% | 1076.3% | 122.6% | 133.8% | 167.3% |
Diluted EPS [+] | | | ($7.01) | ($7.15) | ($7.89) | ($1.52) | ($1.11) | ($1.10) |
Growth | | | 531.0% | 548.9% | 1076.3% | 122.6% | 133.8% | 167.3% |
|
Shares outstanding (basic) [+] | | | 18.7 | 18.0 | 17.1 | 16.3 | 16.1 | 15.9 |
Growth | | | 16.3% | 13.0% | 8.1% | 3.5% | 6.5% | 8.4% |
Shares outstanding (diluted) [+] | | | 18.7 | 18.0 | 17.1 | 16.3 | 16.1 | 15.9 |
Growth | | | 16.3% | 13.0% | 8.1% | 3.5% | 6.5% | 8.4% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |